Abstract
The suprachoroidal space has most certainly been a fascinating yet frustrating space for glaucoma specialists. Much effort has been made to explore the potential of uveoscleral outflow with variable success. Its pharmacologic manipulation using prostaglandin analogues has been a significant achievement in glaucoma medication development. On the other hand, surgical exploration of the suprachoroidal space in glaucoma has been met with disappointments. Cyclodialysis cleft offers significant yet unpredictable IOP lowering. Supraciliary drainage devices have led to complications and failure due to fibrotic response. This chapter describes the latest developments in the exploration of the suprachoroidal space for the treatment of glaucoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nilsson SF. The uveoscleral outflow routes. Eye (Lond). 1997;11(Pt 2):149–54. https://doi.org/10.1038/eye.1997.43.PMID:9349404.
Johnson M, McLaren JW, Overby DR. Unconventional aqueous humor outflow: a review. Exp Eye Res. 2017;158:94–111. https://doi.org/10.1016/j.exer.2016.01.017.
Camras CB, Alm A. Initial clinical studies with prostaglandins and their analogues. Surv Ophthalmol. 1997;41(Suppl 2):S61–8. https://doi.org/10.1016/s0039-6257(97)80009-4.
Gabelt BT, Kaufman PL. The effect of prostaglandin F2 alpha on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res. 1990;51(1):87–91. https://doi.org/10.1016/0014-4835(90)90174-s.
Gills JP, Paterson CA, Paterson ME. Cyclodialysis studied by manometric techniques in the monkey. Br J Ophthalmol. 1967;51(3):199–205. https://doi.org/10.1136/bjo.51.3.199.
Ioannidis AS, Barton K. Cyclodialysis cleft: causes and repair. Curr Opin Ophthalmol. 2010;21(2):150–4. https://doi.org/10.1097/ICU.0b013e3283366a4d.
González-MartÃn-Moro J, Contreras-MartÃn I, Muñoz-Negrete FJ, Gómez-Sanz F, Zarallo-Gallardo J. Cyclodialysis: an update. Int Ophthalmol. 2017;37(2):441–57. https://doi.org/10.1007/s10792-016-0282-8.
Jing Q, Chen J, Chen J, Tang Y, Lu Y, Jiang Y. Cionni-modified capsular tension ring for surgical repair of cyclodialysis after trabeculectomy: a case report. BMC Ophthalmol. 2017;17(1):196. https://doi.org/10.1186/s12886-017-0582-4.
Mardelli PG. Closure of persistent cyclodialysis cleft using the haptics of the intraocular lens. Am J Ophthalmol. 2006;142(4):676–8. https://doi.org/10.1016/j.ajo.2006.05.027.
Helbig H, Foerster MH. Management of hypotonous cyclodialysis with pars plana vitrectomy, gas tamponade, and cryotherapy. Ophthalmic Surg Lasers. 1996;27(3):188–91.
Böke H. Zur Geschichte der Zyklodialyse. In memoriam Leopold Heine 1870-1940 [History of cyclodialysis. In memory of Leopold Heine 1870-1940]. Klin Monatsbl Augenheilkd. 1990;197(4):340–8. https://doi.org/10.1055/s-2008-1046291.
Aviner Z. Modified Krasnov’s iridocycloretraction for aphakic glaucoma. Ann Ophthalmol. 1975;7(6):859–61.
Barkan O, Boyle SF, Maisler S. On the surgery of glaucoma: mode of action of cyclodialysis. Cal West Med. 1936;44(1):12–6.
Flieringa HJ. Cyclodialysis combined with posterior trephining. Br J Ophthalmol. 1952;36(9):518–9. https://doi.org/10.1136/bjo.36.9.518.
Dada T, Sharma R, Sinha G, Angmo D, Temkar S. Cyclodialysis-enhanced trabeculectomy with triple ologen implantation. Eur J Ophthalmol. 2016;26(1):95–7. https://doi.org/10.5301/ejo.5000633.
Gills JP. Cyclodialysis implants in human eyes. Am J Ophthalmol. 1966;61(5 Pt 1):841–6. https://doi.org/10.1016/0002-9394(66)90922-6.
Gills JP Jr, Paterson CA, Paterson ME. Mode of action of cyclodialysis implants in man. Investig Ophthalmol. 1967;6(2):141–4.
Nesterov AP, Kolesnikova LN. Implantation of a scleral strip into the supraciliary space and cyclodialysis in glaucoma. Acta Ophthalmol. 1978;56(5):697–704. https://doi.org/10.1111/j.1755-3768.1978.tb06633.x.
Ozdamar A, Aras C, Karacorlu M. Suprachoroidal seton implantation in refractory glaucoma: a novel surgical technique. J Glaucoma. 2003;12(4):354–9. https://doi.org/10.1097/00061198-200308000-00010.
Melamed S, Ben Simon GJ, Goldenfeld M, Simon G. Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: a pilot study. Arch Ophthalmol. 2009;127(3):264–9. https://doi.org/10.1001/archophthalmol.2008.611.
Figus M, Lazzeri S, Fogagnolo P, Iester M, Martinelli P, Nardi M. Supraciliary shunt in refractory glaucoma. Br J Ophthalmol. 2011;95(11):1537–41. https://doi.org/10.1136/bjophthalmol-2011-300308.
Skaat A, Sagiv O, Kinori M, Ben Simon GJ, Goldenfeld M, Melamed S. Gold micro-shunt implants versus Ahmed glaucoma valve: long-term outcomes of a prospective randomized clinical trial. J Glaucoma. 2016;25(2):155–61. https://doi.org/10.1097/IJG.0000000000000175.
Hueber A, Roters S, Jordan JF, Konen W. Retrospective analysis of the success and safety of Gold Micro Shunt Implantation in glaucoma. BMC Ophthalmol. 2013;13:35. https://doi.org/10.1186/1471-2415-13-35.
Figus M, Posarelli C, Passani A, et al. The supraciliary space as a suitable pathway for glaucoma surgery: Ho-hum or home run? Surv Ophthalmol. 2017;62(6):828–37. https://doi.org/10.1016/j.survophthal.2017.05.002.
Rękas M, Pawlik B, Grala B, Kozłowski W. Clinical and morphological evaluation of gold micro shunt after unsuccessful surgical treatment of patients with primary open-angle glaucoma. Eye (Lond). 2013;27(10):1214–7. https://doi.org/10.1038/eye.2013.154.
Höh H, Grisanti S, Grisanti S, Rau M, Ianchulev S. Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monatsbl Augenheilkd. 2014;231(4):377–81. https://doi.org/10.1055/s-0034-1368214.
Vold S, Ahmed II, Craven ER, et al. Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology. 2016;123(10):2103–12. https://doi.org/10.1016/j.ophtha.2016.06.032.
GarcÃa-Feijoo J, Rau M, Grisanti S, et al. Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study. Am J Ophthalmol. 2015;159(6):1075–1081.e1. https://doi.org/10.1016/j.ajo.2015.02.018.
Manasses DT, Au L. The new era of glaucoma micro-stent surgery. Ophthalmol Ther. 2016;5:135–46.
Junemann A. Twelve-month outcomes following ab interno implantation of suprachoroidal stent and postoperative administration of travoprost to treat open-angle glaucoma. Amsterdam, Netherlands: 31st Congress of the European Society of Cataract and Refractive Surgeons; Oct, 2013.
Myers JS, Masood I, Hornbeak DM, Belda JI, Auffarth G, Jünemann A, Giamporcaro JE, Martinez-de-la-Casa JM, Ahmed IIK, Voskanyan L, Katz LJ. Prospective evaluation of two Istent® trabecular stents, one Istent Supra® suprachoroidal stent, and postoperative prostaglandin in refractory glaucoma: 4-year outcomes. Adv Ther. 2018 Mar;35(3):395–407.
Denis P, Hirneiß C, Reddy KS, Kamarthy A, Calvo E, Hussain Z, Ahmed IIK. A first-in-human study of the efficacy and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-I). Ophthalmol Glaucoma. 2019;2:290–7.
Fili S, Wolfelschneider P, Kohlhaas M. The STARflo glaucoma implant: preliminary 12 months results. Graefes Arch Clin Exp Ophthalmol. 2018;256(4):773e781.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Au, L., Fea, A. (2021). Suprachoroidal Space and Glaucoma. In: Saidkasimova, S., Williamson, T.H. (eds) Suprachoroidal Space Interventions. Springer, Cham. https://doi.org/10.1007/978-3-030-76853-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-76853-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-76852-2
Online ISBN: 978-3-030-76853-9
eBook Packages: MedicineMedicine (R0)